VeriMomnicotinoyl dipeptide-22 est-il sûr pendant la grossesse ?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment flags were identified for nicotinoyl dipeptide-22. No peer-reviewed reproductive toxicity data were found for this ingredient specifically; parent nicotinic acid is not classified for reproductive toxicity. Given topical cosmetic use and lack of hazard data, default hazard and mechanism scores are 0. Exposure is scored as low but measurable for adult topical use (small peptide conjugates can have some dermal bioavailability depending on formulation) (sources: CosIng, PubChem, ECHA C&L absence).
Pregnancy-safe products containing nicotinoyl dipeptide-22
Related ingredients
Frequently asked questions
- nicotinoyl dipeptide-22 est-il sûr pendant la grossesse ?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment flags were identified for nicotinoyl dipeptide-22. No peer-reviewed reproductive toxicity data were found for this ingredient specifically; parent nicotinic acid is not classified for reproductive toxicity. Given topical cosmetic use and lack of hazard data, default hazard and mechanism scores are 0. Exposure is scored as low but measurable for adult topical use (small peptide conjugates can have some dermal bioavailability depending on formulation) (sources: CosIng, PubChem, ECHA C&L absence).
- nicotinoyl dipeptide-22 est-il sûr pendant l'allaitement ?
- No evidence of reproductive or lactation-specific toxicity; no regulatory flags. Breastfeeding exposure potential follows pregnancy: low but measurable systemic absorption from topical use cannot be excluded; no data on secretion in milk (sources: CosIng, PubChem, ECHA C&L absence).
- nicotinoyl dipeptide-22 est-il sûr pour la peau de bébé ?
- No infant-specific hazard or mechanism data were identified. By default hazard and mechanism remain 0. Exposure score is increased by +1 for babies (per instructions) to account for higher surface-area-to-weight ratio and immature barrier if the adult exposure is low/measurable; therefore baby exposure = 2. No infant dermal absorption or toxicity studies were found for this ingredient (sources: CosIng, PubChem).
- Comment VeriMom évalue-t-il nicotinoyl dipeptide-22 ?
- VeriMom évalue nicotinoyl dipeptide-22 à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à nicotinoyl dipeptide-22 pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à nicotinoyl dipeptide-22 basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.